Results 121 to 130 of about 1,136,512 (313)
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John+5 more
wiley +1 more source
Prematurely Terminated Clinical Trials and Their Application to Cardiovascular Medicine [PDF]
Domenic A. Sica
openalex +1 more source
Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis
This paper describes the development of a microscale model that quantifies the breakdown of fibrin by endothelial cells. The small size scale of this engineered system enables fibrin breakdown to be observed without the addition of external activators. This system could help in identifying compounds which both promote and hinder thrombosis.
Jonathan J. Chang+5 more
wiley +1 more source
Egg‐shaped aortic thrombi associated with COVID‐19
Ibuki Kurihara+4 more
doaj +1 more source
Partnership in cardiovascular medicine. A key to success not only for professional organizations [PDF]
Lars Rydén
openalex +1 more source
The top‐performing lipid nanoparticle, incorporating a novel ionizable lipid derived from vitamin B5, demonstrates high mRNA transfection efficiency, low toxicity, favorable stability, targeted delivery to lymphoid tissues, and high immunogenicity, showing promise as a carrier for mRNA vaccines for infectious diseases and cancer.
Soyeon Yoo+11 more
wiley +1 more source
Hani Jneid
doaj +1 more source
Cardiovascular risk profile of a Spanish hypertensive population in primary care medicine. DIORISK study [PDF]
Vicente Barrios
openalex +1 more source